1. HMG CoA reductase inhibitors and PPAR-α activators: Are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?

   • Jean-Charles Fruchart
   • Patrick Duriez

   Invited Commentary Pages: 403 - 404

2. Literature alert

   • Joel B. Braunstein

   Announcement Pages: 406 - 407

3. Clinical trials report

   • Penny M. Kris-Etherton

   OriginalPaper Pages: 411 - 413

4. Update on the role of triglycerides as a risk factor for coronary heart disease

   • Michael Miller
   • Barbara Cosgrove
   • Stephen Havas

   OriginalPaper Pages: 414 - 418

5. Dietary fats and coronary heart disease pathogenesis

   • Serge Renaud
   • Dominique Lanzmann-Petithory

   OriginalPaper Pages: 419 - 424

6. Dietary cholesterol and coronary heart disease

   • William E. Connor
   • Sonja L. Connor

   OriginalPaper Pages: 425 - 432

7. Therapeutic lifestyle change and adult treatment panel III: Evidence then and now

   • Neil J. Stone
   • Linda Van Horn

   OriginalPaper Pages: 433 - 443

8. Metabolic syndrome

   • Margo A. Denke

   OriginalPaper Pages: 444 - 447

9. Obesity and cardiovascular disease

   • Paul Poirier
   • Robert H. Eckel

   OriginalPaper Pages: 448 - 453

10. Dietary glycemic load and atherothrombotic risk

    • Simin Liu
    • Walter C. Willett

    OriginalPaper Pages: 454 - 461

11. Dietary patterns and risk of hypertension, type 2 diabetes mellitus, and coronary heart disease

    • Matthias B. Schulze
    • Frank B. Hu

    OriginalPaper Pages: 462 - 467

12. Cardiorespiratory fitness and physical activity as risk predictors of future atherosclerotic cardiovascular diseases

    • Jari A. Laukkanen
    • Sudhir Kurl
    • Jukka T. Salonen

    OriginalPaper Pages: 468 - 476

13. Web alert

    • Robert Chilton

    Announcement Pages: 477 - 477